Javascript must be enabled to continue!
The Impact of the Interaction between Intestinal Flora and Intestinal Wall Immune Microenvironment on Ulcerative Colitis
View through CrossRef
Ulcerative colitis (UC) is a chronic, non-specific inflammatory disease of the intestine with an unknown etiology. The primary clinical manifestations include recurrent abdominal pain, diarrhea, mucus and purulent discharge, bloody stools, and tenesmus. Experts generally agree that the onset of this disease is primarily associated with factors such as intestinal flora, dietary composition, genetics, immunity, infections, and systemic inflammation. The intestinal flora constitutes the largest microecological system within the human body, consisting of a vast array of microorganisms that interact dynamically with the immune cells located in the intestinal wall. This interaction is crucial for maintaining a balance with the intestinal mucosa. The intestinal flora plays a significant role in the development of the immune system, sustaining normal immune function, and cooperatively countering the invasion of pathogenic bacteria. Alterations in the composition of the intestinal flora can influence the equilibrium between intestinal tolerance and immunity. Research has demonstrated that the disease process in UC patients is closely linked to disturbances in the structure of the intestinal bacterial flora,and symptoms can be significantly alleviated following the transplantation of normal flora. Therefore,Modulating the structure of the intestinal microbiota may serve as an effective strategy for treating ulcerative colitis (UC). This article examines the relationship between intestinal flora and intestinal wall immunity in the context of UC, while also exploring novel approaches for its treatment.
Al-Kindi Center for Research and Development
Title: The Impact of the Interaction between Intestinal Flora and Intestinal Wall Immune Microenvironment on Ulcerative Colitis
Description:
Ulcerative colitis (UC) is a chronic, non-specific inflammatory disease of the intestine with an unknown etiology.
The primary clinical manifestations include recurrent abdominal pain, diarrhea, mucus and purulent discharge, bloody stools, and tenesmus.
Experts generally agree that the onset of this disease is primarily associated with factors such as intestinal flora, dietary composition, genetics, immunity, infections, and systemic inflammation.
The intestinal flora constitutes the largest microecological system within the human body, consisting of a vast array of microorganisms that interact dynamically with the immune cells located in the intestinal wall.
This interaction is crucial for maintaining a balance with the intestinal mucosa.
The intestinal flora plays a significant role in the development of the immune system, sustaining normal immune function, and cooperatively countering the invasion of pathogenic bacteria.
Alterations in the composition of the intestinal flora can influence the equilibrium between intestinal tolerance and immunity.
Research has demonstrated that the disease process in UC patients is closely linked to disturbances in the structure of the intestinal bacterial flora,and symptoms can be significantly alleviated following the transplantation of normal flora.
Therefore,Modulating the structure of the intestinal microbiota may serve as an effective strategy for treating ulcerative colitis (UC).
This article examines the relationship between intestinal flora and intestinal wall immunity in the context of UC, while also exploring novel approaches for its treatment.
Related Results
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Osteopathic Primary Care Treatment Options for Ulcerative Colitis
Ulcerative colitis is a multifactorial, chronic inflammatory disease of the bowel that can cause physical, social and emotional injury to the patient. While perhaps not always maki...
P0050 4-Octyl Itaconate Protects Against Colitis by Modulating Neutrophil Function and Enhancing Intestinal Epithelial Barrier Integrity
P0050 4-Octyl Itaconate Protects Against Colitis by Modulating Neutrophil Function and Enhancing Intestinal Epithelial Barrier Integrity
Abstract
Background
Inflammatory bowel disease (IBD) is a complex gastrointestinal condition marked by immune system dysfunction...
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Comparison of PUCAI Score in Mesalazine-Treated Children with Ulcerative Colitis
Background: Ulcerative colitis is a chronic idiopathic inflammatory bowel disease (IBD) characterized by intestinal inflammation confined to the superficial mucosal layer. Mesalazi...
Dual-pathway mechanisms of plant-derived polysaccharides in ulcerative colitis: integrative roles of microbiota modulation, immune regulation, and barrier restoration
Dual-pathway mechanisms of plant-derived polysaccharides in ulcerative colitis: integrative roles of microbiota modulation, immune regulation, and barrier restoration
Chronic inflammation of the colon has been described as an inflammatory condition of the colon that is characterized by recurring flare-ups of the disease (ulcerative colitis). Ulc...
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
P0193 Oral administration of Sophora Flavescens-derived exosomes-like nanovesicles carrying CX5461 ameliorates DSS-induced colitis in mice
Abstract
Background
Ulcerative colitis (UC) belongs inflammatory disease with chronic and relapsing characterizations and increa...
Pharmacological correction of ulcerative colitis with dalargin
Pharmacological correction of ulcerative colitis with dalargin
Introduction: Ulcerative colitis is a chronic colonic disease with frequent relapses, affecting mainly people of active age. The effectiveness of existing treatment methods remains...
A Clinical Review on Ulcerative Colitis (Colon Cancer)
A Clinical Review on Ulcerative Colitis (Colon Cancer)
Ulcerative colitis (UC) is also known as colon cancer or colorectal cancer, a chronic inflammatory condition of the large intestine (colon and rectum). It comes under blood in stoo...
CD8+ Lymphocyte Infiltration is a Specific Feature of Colitis Induced By Immune Checkpoint Inhibitors
CD8+ Lymphocyte Infiltration is a Specific Feature of Colitis Induced By Immune Checkpoint Inhibitors
Abstract
Background
Immune checkpoint inhibitors (ICPIs) have revolutionized cancer therapy, although immune-related adverse events (irAEs) remain a severe issue. The clin...

